SG Americas Securities
NDRM

SG Americas Securities’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

SG Americas Securities’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-34,367
Closed -$1.34M – 3971
2017
Q3 		$1.34M Buy
+34,367
New +$1.26M 0.01% 1056

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

SG Americas Securities's NDRM Position: Q4 2017 in Review

SG Americas Securities sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 34,367 shares — an estimated $1.34M sold.

SG Americas Securities first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $1.34M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • SG Americas Securities reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • SG Americas Securities sold 34,367 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.34M.
  • SG Americas Securities first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • SG Americas Securities's NeuroDerm Ltd. Ordinary Shares position peaked at $1.34M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.